Skip to main content
// //

FDA, EU diverge on AstraZeneca's potential COVID-19 vaccine

The FDA widened its probe into a serious illness linked to trials for AstraZeneca's potential COVID-19 vaccine, while in Europe the approval process has been fast-tracked.

Reuters

More videos

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies